Category

Insights
CADTH Symposium 2023: Is Canada Ready?

CADTH Symposium 2023: Is Canada Ready?

Medlior’s Founder and President Tara Cowling was delighted to attend the CADTH Symposium 2023 in Ottawa last week. On the heels of the ISPOR 2023 conference, CADTH also tackled some key issues surrounding the use of RWE to inform decision-making.

2022: A Year in Review

2022: A Year in Review

As we slowly emerged from our COVID caves of 2020-2021, this year brought great excitement to Medlior.  We helped industry bring life-changing innovations to market, and we increased our stakeholder collaboration.

Men’s Mental Health: A Silent Crisis

Men’s Mental Health: A Silent Crisis

November is men’s health awareness month – and some of the less-often-talked about health issues affecting men are about their mental health. The Canadian Mental Health Association is calling this a “silent crisis, a sleeper issue”.

CADTH RWE Framework

CADTH RWE Framework

I had the pleasure of attending the The Canadian Association for Population Therapeutics annual conference in Toronto, Canada. The program was titled “Embracing Change and Uncertainty to Improve the Health of Canadians” and it was kicked-off with a townhall session on Canadian RWE Initiatives…

Early Diagnosis of Alzheimer’s Disease Using AI Techniques in Primary Care

Early Diagnosis of Alzheimer’s Disease Using AI Techniques in Primary Care

Alzheimer’s disease (AD) is a degenerative neurological disease with progressive death of brain cells, eventually leading to death.1,2 It is the most prevalent irreversible dementia, marked by deterioration of memory, judgement, and reasoning and worsening of mood, behaviour, communication, and function to perform daily activities.1 With longer life expectancy and an aging population, the burden of AD on the quality of life of patients and their family and caregivers is increasing.